Royalty Pharma shareholders elect all eight directors at June 6 AGM; all proposals pass

Royalty Pharma plc

All eight director nominees elected with 457M–482M For votes; broker non-votes 24.8M per nominee.
Advisory say-on-pay approved (448.1M For, 37.7M Against); auditor Ernst & Young LLP ratified (510.5M For).
UK statutory accounts, directors' remuneration policy and report all passed with majority support.
Share allotment authorities (proposals 9 & 10) approved with over 455M For votes each.
Quorum of 85.49% of combined voting power represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.